Chance Brock, M.D.
chance.brock@cuanschutz.eduHometown
Buckley, WA
Training/Education
College: Bachelor of Science, BioChemistry, Pacific Lutheran University
Medical School: Washington State University
Internship Institution: University of New Mexico
Professional Interests
Considering a few different options in MSK, body, or chest, but open to new experiences.
Hobbies
Surviving intern year, hiking, snowboarding, video games, reading, and hanging with my wife and dog.
What are you looking forward to doing in the Denver area?
Most of my hobbies align well with what Denver has to offer. I'm also looking forward to doing things with my cohort.
Most rewarding moment of residency?
Before medical school, I did research for 4 years at Fred Hutchinson Cancer Research in Seattle, WA. I had a lot of opportunities to work on novel research, as well as, meet a lot of accomplished people that helped me realize my interest in pursuing medicine and radiology.
Professional Organizations, Boards, and Advisory Committees
President of Radiology Club, 3 years
Publications
Johnston MG, Burke S, Brock CM, Beckius S, King S. Standardized Follow-Up Recommendations Improve Reporting of Incidental Renal Lesions in a Community Setting. Cureus. 2023 Jun 22;15(6):e40828. doi: 10.7759/cureus.40828. PMID: 37489204; PMCID: PMC10363255.Sholukh AM, Fiore-Gartland A, Ford ES, Miner MD, Hou YJ, Tse LV, Kaiser H, Zhu H, Lu J, Madarampalli B, Park A, Lempp FA, St Germain R, Bossard EL, Kee JJ, Diem K, Stuart AB, Rupert PB, Brock C, Buerger M, Doll MK, Randhawa AK, Stamatatos L, Strong RK, McLaughlin C, Huang ML, Jerome KR, Baric RS, Montefiori D, Corey L. Evaluation of Cell-Based and Surrogate SARS-CoV-2 Neutralization Assays. J Clin Microbiol. 2021 Sep 20;59(10):e0052721. doi: 10.1128/JCM.00527-21. Epub 2021 Jul 21. PMID: 34288726; PMCID: PMC8451402.
Finton KAK, Brusniak MY, Jones LA, Lin C, Fioré-Gartland AJ, Brock C, Gafken PR, Strong RK. ARTEMIS: A Novel Mass-Spec Platform for HLA-Restricted Self and Disease-Associated Peptide Discovery. Front Immunol. 2021 Apr 23;12:658372. doi: 10.3389/fimmu.2021.658372. PMID: 33986749; PMCID: PMC8111693.
Sholukh AM, Fiore-Gartland A, Ford ES, Hou Y, Tse LV, Lempp FA, Kaiser H, Saint Germain R, Bossard E, Kee JJ, Diem K, Stuart AB, Rupert PB, Brock C, Buerger M, Doll MK, Randhawa AK, Stamatatos L, Strong RK, McLaughlin C, Jerome KR, Baric RS, Montefiori D, Corey L. Evaluation of SARS-CoV-2 neutralization assays for antibody monitoring in natural infection and vaccine trials. medRxiv [Preprint]. 2020 Dec 8:2020.12.07.20245431. doi: 10.1101/2020.12.07.20245431. PMID: 33330875; PMCID: PMC7743084.